Pharmacogenetics and Drug Development
Abstract:This chapter examines the application of pharmacogenetics to drug development. It explains why there has been a recent slowdown in discovery and development of new medicines and how pharmacogenetics may help address this problem. It discusses how application of genetic biomarkers will affect drug development. Such an approach can, in principle, reduce the costs of clinical trials for prospective medicines while increasing the probability that potential products might reach the market.
Document Type: Review Article
Publication date: 2009-11-01